Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
Sanuwave Health (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, has scheduled a conference call to discuss its Q2 2025 financial results on Friday, August 8, 2025, at 8:30 AM ET.
Investors can access the call via toll-free number 1-800-245-3047 or international number 1-203-518-9765 using Conference ID: SANUWAVE. A webcast link is also available. Presentation materials will be accessible on the company's investor relations website, and a replay will be available through August 29, 2025.
Sanuwave Health (NASDAQ: SNWV), un fornitore leader di prodotti per la cura delle ferite di nuova generazione approvati dalla FDA, ha programmato una conference call per discutere i risultati finanziari del secondo trimestre 2025 venerd矛 8 agosto 2025 alle 8:30 ET.
Gli investitori potranno partecipare alla chiamata tramite il numero verde 1-800-245-3047 o il numero internazionale 1-203-518-9765 utilizzando il codice conferenza: SANUWAVE. 脠 disponibile anche un link per la trasmissione in webcast. I materiali della presentazione saranno consultabili sul sito web delle relazioni con gli investitori dell'azienda e una registrazione sar脿 disponibile fino al 29 agosto 2025.
Sanuwave Health (NASDAQ: SNWV), un proveedor l铆der de productos para el cuidado de heridas de pr贸xima generaci贸n aprobados por la FDA, ha programado una llamada de conferencia para discutir los resultados financieros del segundo trimestre de 2025 el viernes 8 de agosto de 2025 a las 8:30 AM ET.
Los inversionistas pueden acceder a la llamada mediante el n煤mero gratuito 1-800-245-3047 o el n煤mero internacional 1-203-518-9765 usando el ID de conferencia: SANUWAVE. Tambi茅n est谩 disponible un enlace para la transmisi贸n en vivo. Los materiales de la presentaci贸n estar谩n disponibles en el sitio web de relaciones con inversionistas de la compa帽铆a y una repetici贸n estar谩 accesible hasta el 29 de agosto de 2025.
Sanuwave Health (NASDAQ: SNWV)電� FDA 鞀轨澑 彀劯雽� 靸侅矘 旃橂 鞝滍拡鞚� 靹犽弰 鞐呾泊搿滌劀, 2025雲� 8鞗� 8鞚� 旮堨殧鞚� 鞓れ爠 8鞁� 30攵�(霃欕秬鞁滉皠)鞐� 2025雲� 2攵勱赴 鞛 瓴瓣臣毳� 雲检潣頃橁赴 鞙勴暅 旎嵓霟办姢 旖滌潉 鞓堨爼頄堨姷雼堧嫟.
韴瀽鞛愲摛鞚� 氍措 鞝勴檾氩堩樃 1-800-245-3047 霕愲姅 甑牅 鞝勴檾氩堩樃 1-203-518-9765毳� 韱淀暣 旎嵓霟办姢 ID: SANUWAVE毳� 靷毄頃橃棳 韱淀檾鞐� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼 毵來伂霃� 鞝滉车霅╇媹雼�. 氚滍憸 鞛愲電� 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 頇曥澑頃� 靾� 鞛堨溂氅�, 2025雲� 8鞗� 29鞚缄箤歆� 雼れ嫓 霌ｊ赴臧� 臧�電ロ暕雼堧嫟.
Sanuwave Health (NASDAQ : SNWV), un fournisseur de premier plan de produits de soins des plaies de nouvelle g茅n茅ration approuv茅s par la FDA, a programm茅 une conf茅rence t茅l茅phonique pour discuter des r茅sultats financiers du deuxi猫me trimestre 2025 le vendredi 8 ao没t 2025 脿 8h30 ET.
Les investisseurs peuvent acc茅der 脿 l'appel via le num茅ro vert 1-800-245-3047 ou le num茅ro international 1-203-518-9765 en utilisant l'ID de conf茅rence : SANUWAVE. Un lien webcast est 茅galement disponible. Les supports de pr茅sentation seront accessibles sur le site des relations investisseurs de la soci茅t茅, et une rediffusion sera disponible jusqu'au 29 ao没t 2025.
Sanuwave Health (NASDAQ: SNWV), ein f眉hrender Anbieter von FDA-zugelassenen Wundversorgungsprodukten der n盲chsten Generation, hat eine Telefonkonferenz zur Besprechung der Finanzergebnisse des zweiten Quartals 2025 f眉r Freitag, den 8. August 2025, um 8:30 Uhr ET angesetzt.
Investoren k枚nnen die Telefonkonferenz 眉ber die geb眉hrenfreie Nummer 1-800-245-3047 oder die internationale Nummer 1-203-518-9765 mit der Konferenz-ID: SANUWAVE verfolgen. Ein Webcast-Link ist ebenfalls verf眉gbar. Pr盲sentationsmaterialien sind auf der Investor-Relations-Website des Unternehmens abrufbar, und eine Aufzeichnung wird bis zum 29. August 2025 verf眉gbar sein.
- None.
- None.
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave鈥�) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 8, 2025, at 8:30 AM (ET) to present its Q2 2025 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information聽
Toll Free: 1-800-245-3047
Toll/International: 1-203-518-9765
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event:聽
Materials for the conference call will be included on the Company鈥檚 website at聽.
A replay will be made available through August 29, 2025:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11159256
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body鈥檚 normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain 鈥渇orward-looking statements鈥� within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company鈥檚 ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company鈥檚 ability to manage its capital resources, competition and the other factors discussed in detail in the Company鈥檚 periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
FAQ
When is Sanuwave's (SNWV) Q2 2025 earnings call?
How can investors access Sanuwave's (SNWV) Q2 2025 earnings call?
Where can I find Sanuwave's (SNWV) Q2 2025 earnings presentation materials?
Until when will Sanuwave's (SNWV) Q2 2025 earnings call replay be available?
